Guilford, CT, United States of America

Jan William Wasley

USPTO Granted Patents = 30 


 

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 120(Granted Patents)


Location History:

  • Essex, CT (US) (1995 - 1999)
  • Madison, CT (US) (1997 - 1999)
  • Guilford, CT (US) (1997 - 2017)

Company Filing History:


Years Active: 1995-2017

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Jan William Wasley

Introduction

Jan William Wasley, located in Guilford, CT, is a prolific inventor with an impressive portfolio of 30 patents to his name. His work primarily revolves around the field of biochemistry, particularly focusing on therapeutic agents that target specific enzyme inhibitors.

Latest Patents

Among his latest innovations are two notable patents. The first is titled "Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents." This invention is aimed at developing inhibitors of S-nitrosoglutathione reductase (GSNOR), which include pharmaceutical compositions and methods for their application. The second patent, "Chromone inhibitors of S-nitrosoglutathione reductase," similarly targets GSNOR inhibitors, contributing valuable insights and potential therapeutic solutions in medicinal chemistry.

Career Highlights

Throughout his career, Jan Hasley worked with esteemed companies such as Neurogen Corporation and N30 Pharmaceuticals, Inc. His positions at these organizations enabled him to collaborate on cutting-edge research and development projects, fostering significant advancements in drug discovery and therapeutic innovation.

Collaborations

Jan has collaborated with prominent professionals in his field, including colleagues Xicheng David Sun and Jian Qiu. These collaborations have enhanced the scope of his inventions, leading to impactful developments in the biopharmaceutical landscape.

Conclusion

Jan William Wasley's contributions to the field of therapeutics through his numerous patents demonstrate a deep commitment to innovation and improvement in health care solutions. His work, particularly in the area of S-nitrosoglutathione reductase inhibitors, continues to pave the way for future advancements and research in pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…